Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bococizumab cardiovascular outcomes trial in high-risk patients
2013-002646-36Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atherosclerosis and cardiac morbidity comparing Bococizumab with Placebo (2 arms). Started Nov 2013; status: completed.
02
Drugs
bococizumab
03
Conditions
atherosclerosiscardiac morbidity
Beyond the preview
Go deeper on 2013-002646-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002646-36.